Form 8-K - Current report:
SEC Accession No. 0001193125-24-283722
Filing Date
2024-12-23
Accepted
2024-12-23 08:37:31
Documents
53
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889670d8k.htm   iXBRL 8-K 77040
2 EX-2.1 d889670dex21.htm EX-2.1 1727164
3 EX-10.1 d889670dex101.htm EX-10.1 110217
4 EX-10.2 d889670dex102.htm EX-10.2 107650
5 EX-10.3 d889670dex103.htm EX-10.3 148978
6 EX-10.4 d889670dex104.htm EX-10.4 61584
7 EX-10.5 d889670dex105.htm EX-10.5 55076
8 EX-10.6 d889670dex106.htm EX-10.6 31545
9 EX-10.7 d889670dex107.htm EX-10.7 225575
10 EX-99.1 d889670dex991.htm EX-99.1 25611
11 EX-99.2 d889670dex992.htm EX-99.2 47106
15 GRAPHIC g889670dsp051.jpg GRAPHIC 4587
16 GRAPHIC g889670dsp1.jpg GRAPHIC 3282
17 GRAPHIC g889670ex99_2s10g1.jpg GRAPHIC 93816
18 GRAPHIC g889670ex99_2s11g1.jpg GRAPHIC 102721
19 GRAPHIC g889670ex99_2s12g1.jpg GRAPHIC 109879
20 GRAPHIC g889670ex99_2s13g1.jpg GRAPHIC 95619
21 GRAPHIC g889670ex99_2s14g1.jpg GRAPHIC 80338
22 GRAPHIC g889670ex99_2s15g1.jpg GRAPHIC 100806
23 GRAPHIC g889670ex99_2s16g1.jpg GRAPHIC 77438
24 GRAPHIC g889670ex99_2s17g1.jpg GRAPHIC 67270
25 GRAPHIC g889670ex99_2s18g1.jpg GRAPHIC 92786
26 GRAPHIC g889670ex99_2s19g1.jpg GRAPHIC 76921
27 GRAPHIC g889670ex99_2s1g1.jpg GRAPHIC 55898
28 GRAPHIC g889670ex99_2s20g1.jpg GRAPHIC 79028
29 GRAPHIC g889670ex99_2s21g1.jpg GRAPHIC 79335
30 GRAPHIC g889670ex99_2s22g1.jpg GRAPHIC 112478
31 GRAPHIC g889670ex99_2s23g1.jpg GRAPHIC 88963
32 GRAPHIC g889670ex99_2s24g1.jpg GRAPHIC 102679
33 GRAPHIC g889670ex99_2s25g1.jpg GRAPHIC 134882
34 GRAPHIC g889670ex99_2s26g1.jpg GRAPHIC 49732
35 GRAPHIC g889670ex99_2s27g1.jpg GRAPHIC 43665
36 GRAPHIC g889670ex99_2s2g1.jpg GRAPHIC 172657
37 GRAPHIC g889670ex99_2s3g1.jpg GRAPHIC 105070
38 GRAPHIC g889670ex99_2s4g1.jpg GRAPHIC 146812
39 GRAPHIC g889670ex99_2s5g1.jpg GRAPHIC 98096
40 GRAPHIC g889670ex99_2s6g1.jpg GRAPHIC 75384
41 GRAPHIC g889670ex99_2s7g1.jpg GRAPHIC 99268
42 GRAPHIC g889670ex99_2s8g1.jpg GRAPHIC 84380
43 GRAPHIC g889670ex99_2s9g1.jpg GRAPHIC 102462
44 GRAPHIC g889670g16y01.jpg GRAPHIC 25416
  Complete submission text file 0001193125-24-283722.txt   6954428

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA ikna-20241223.xsd EX-101.SCH 2869
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20241223_lab.xml EX-101.LAB 19501
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20241223_pre.xml EX-101.PRE 12169
55 EXTRACTED XBRL INSTANCE DOCUMENT d889670d8k_htm.xml XML 3898
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 241570203
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)